Michael Severino

CEO, Tessera Therapeutics

Vice Chairman & President at AbbVie

Cambridge, Massachusetts

About

Male

Michael Severino is based out of Cambridge, Massachusetts, and is the CEO and Board Director of Tessera Therapeutics. Michael Severino previously worked at AbbVie as a Vice Chairman and President. attended University of Maryland, College Park.

Experience

AbbVie

Vice Chairman & President · 2018 – 2022

View →

IPO15kNorth Chicago, Illinois, United StatesBiotechnology · Financial Services

AbbVie

EVP Research and Development, Chief Scientific Officer · 2014 – 2018

View →

IPO15kNorth Chicago, Illinois, United StatesBiotechnology · Financial Services

CEO · Tessera Therapeutics
2022 – present
Board Director · Tessera Therapeutics

Education

University of Maryland College Park · BS, Biochemistry
The Johns Hopkins University · MD

Headlines from Google News. Social posts load from the platform only when you open a tab.

Struggling Sarepta Therapeutics appoints former AbbVie executive as savior
medwatch.com · Jul 29
Severino takes the helm at Sarepta after turbulent spell
pharmaphorum · Jul 28
Sarepta appoints Michael Severino as new CEO
thepharmaletter.com · Jul 28
Sarepta names former AbbVie R&D exec Michael Severino as next CEO
BioSpace · Jul 27
Sarepta Therapeutics Appoints Michael Severino, M.D., Chief Executive Officer
businesswire.com · Jul 27

People at AbbVie

Adiba Ishaque-Zanghi

Principal Research Scientist I

Almath Spooner

Director Global Regulatory Policy and Intelligence

Amanda Graber Rosenberg

Global Communications Strategy & Planning

Data from: crunchbase